Alzamend Neuro Inc ALZN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/30/22 EDT
1.18quote price arrow down-0.01 (-0.84%)
Volume
6,162
Close
1.19UNCH (UNCH)
Volume
693,434
52 week range
0.80 - 3.57
Loading...
  • Open1.21
  • Day High1.25
  • Day Low1.13
  • Prev Close1.19
  • 52 Week High3.57
  • 52 Week High Date09/30/21
  • 52 Week Low0.80
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap113.62M
  • Shares Out95.48M
  • 10 Day Average Volume1.37M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-37.37

KEY STATS

  • Open1.21
  • Day High1.25
  • Day Low1.13
  • Prev Close1.19
  • 52 Week High3.57
  • 52 Week High Date09/30/21
  • 52 Week Low0.80
  • 52 Week Low Date05/12/22
  • Market Cap113.62M
  • Shares Out95.48M
  • 10 Day Average Volume1.37M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-37.37

RATIOS/PROFITABILITY

  • EPS (TTM)-0.14
  • P/E (TTM)-8.44
  • Fwd P/E (NTM)-5.67
  • EBITDA (TTM)-13.038M
  • ROE (TTM)-98.61%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date12/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alzamend Neuro Inc

 

Profile

MORE
Alzamend Neuro, Inc. is an early clinical-stage biopharmaceutical company. The Company is focused on developing products for the treatment of Alzheimer’s disease (Alzheimer’s), bipolar disorder, major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). The Company's pipeline consists of two therapeutic drug candidates: AL001 and AL002. The AL001 is a cocrystal technology delivering a therapeutic combination of lithium, proline and salicylate, known as AL001...
William Horne
Chairman of the Board
Stephan Jackman
Chief Executive Officer, Director
David Katzoff
Chief Financial Officer
Henry Nisser
Executive Vice President, General Counsel
Address
3500 Lenox Rd. NE, Suite 1500
Atlanta, GA
30326
United States

Top Peers

SYMBOLLASTCHG%CHG
ATOS
Atossa Therapeutics Inc
0.8333+0.0073+0.88%
INZY
Inozyme Pharma Inc
2.68+0.09+3.47%
ETNB
89Bio Inc
5.79+0.33+6.04%
TALS
Talaris Therapeutics Inc
2.63-0.04-1.50%
ANVS
Annovis Bio Inc
13.70+0.04+0.29%